10/18/2024

Janusmed sex and gender

Janusmed sex and gender – retapamulin

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Retapamulin

Retapamulin

Class : A

Show all info

Print

Contact us

  1. Tomayko JF, Li G, Breton JJ, Scangarella-Oman N, Dalessandro M, Martin M. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study. Adv Skin Wound Care. 2013;26:113-21.

  2. ALTABAX ( retapamulin). DailyMed [www]. US National Library of Medicine. [updated 2015-04-20, cited 2016-03-29].

  3. ALTABAX ( retapamulin). Labeling. U.S. Food and Drug Administration (FDA); 2012.

  4. Koning S, van der Wouden JC, Chosidow O, Twynholm M, Singh KP, Scangarella N et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol. 2008;158:1077-82.

  5. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-05-30.]

  1. Tomayko JF, Li G, Breton JJ, Scangarella-Oman N, Dalessandro M, Martin M. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study. Adv Skin Wound Care. 2013;26:113-21.
  2. ALTABAX ( retapamulin). DailyMed [www]. US National Library of Medicine. [updated 2015-04-20, cited 2016-03-29].
  3. ALTABAX ( retapamulin). Labeling. U.S. Food and Drug Administration (FDA); 2012.
  4. Koning S, van der Wouden JC, Chosidow O, Twynholm M, Singh KP, Scangarella N et al. Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. Br J Dermatol. 2008;158:1077-82.
  5. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-05-30.]